Novo Nordisk | NVO - Trade Debtors

Stock Price
47.64
Daily Change
4.32 9.97%
Monthly
-15.74%
Yearly
-44.86%
Q1 Forecast
56.42

Novo Nordisk reported DKK14.27B in Trade Debtors for its fiscal quarter ending in June of 2025.





Trade Debtors Change Date
ANI Pharmaceuticals USD 252.62M 26.96M Sep/2025
Aurora Cannabis CAD 46.73M 7.59M Sep/2025
Bausch Health Companies USD 2.42B 207M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Canopy Growth CAD 26.86M 23.17M Sep/2025
Corcept Therapeutics USD 69.63M 5.06M Sep/2025
Drreddys Laboratories INR 1.41B 11.6M Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Merck USD 12.12B 596M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Novo Nordisk DKK 95.05B 2.4B Dec/2025
Novo Nordisk DKK 14.27B 72.1B Jun/2025
Pacira USD 115.27M 901K Sep/2025
Perrigo USD 644.4M 62.2M Sep/2025
Prestige Brands USD 190.46M 8.54M Dec/2025
Sanofi EUR 397M 100M Dec/2025
Supernus Pharmaceuticals USD 171.25M 30.42M Sep/2025
Zoetis USD 1.54B 1000K Sep/2025